Previous Close | 3.8800 |
Open | 3.9100 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 3.6000 - 3.9100 |
52 Week Range | 2.5000 - 18.0000 |
Volume | |
Avg. Volume | 53,425 |
Market Cap | 6.025M |
Beta (5Y Monthly) | 1.22 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -23.3100 |
Earnings Date | May 10, 2024 - May 13, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 5.00 |
REDWOOD CITY, CA / ACCESSWIRE / May 7, 2024 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today ...
Avinger (AVGR) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Avinger (AVGR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.